GlaxoSmithKline PLC ADR (GSK)
NYSE · Healthcare · Drug Manufacturers - General
GlaxoSmithKline PLC ADR is a Healthcare company with a market capitalization of $105.17B, a trailing P/E ratio of 14.0, and a dividend yield of 3.43%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025 · in GBP
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 29, 2026 | $1.26 | $1.16 | +8.6% |
| Q4 2025 | February 4, 2026 | $0.70 | $0.62 | +12.9% |
| Q3 2025 | October 29, 2025 | $1.46 | $1.26 | +15.9% |
| Q2 2025 | July 30, 2025 | $1.24 | $1.11 | +11.7% |
| Q1 2025 | April 30, 2025 | $1.20 | $1.04 | +15.4% |
| Q4 2024 | February 5, 2025 | $0.58 | $0.49 | +18.4% |
Other Drug Manufacturers - General Stocks
Frequently Asked Questions
What is GlaxoSmithKline PLC ADR's market cap?
As of June 29, 2026, GlaxoSmithKline PLC ADR (GSK) has a market capitalization of $105.17B.
What is GlaxoSmithKline PLC ADR's P/E ratio?
GlaxoSmithKline PLC ADR trades at a trailing price-to-earnings (P/E) ratio of 14.0. Its forward P/E is 22.1.
Does GlaxoSmithKline PLC ADR pay a dividend?
Yes — GlaxoSmithKline PLC ADR pays a dividend yielding 3.43%, an annual payout of $0.67 per share.
What sector is GSK in?
GlaxoSmithKline PLC ADR is in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What was GlaxoSmithKline PLC ADR's revenue?
In its latest reported fiscal year (ending December 31, 2025), GlaxoSmithKline PLC ADR reported revenue of 32.67B GBP and net income of 5.72B GBP.
Ask your own questions about GSK
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.